ABCB1 and chronic myelogenous leukemia, BCR-ABL1 positive: Despite some recent findings demonstrating that TCF consensus sites for β-catenin were functional in the ABCB1 promoter in other types of cancer, in CML, this regulation has not yet been investigated.